Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

November 1, 2026

Conditions
Major BleedingMajor Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Trial Locations (1)

11184

Istishari Hospital, Amman

All Listed Sponsors
lead

Jordan Collaborating Cardiology Group

OTHER